{
  "id": 3807674,
  "title": "Eli Lilly study aims to bolster case for long-term Zepbound benefits",
  "url": "https://urgent.news/2026/08/27/eli-lilly-study-aims-to-bolster-case-for-long-term-zepbound-benefits",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-27T18:07:16.000Z",
  "source": {
    "name": "Fierce Healthcare",
    "slug": "fierce-healthcare",
    "url": "https://www.fiercehealthcare.com/payers/eli-lilly-study-aims-bolster-case-long-term-zepbound-benefits"
  },
  "original_language": "en",
  "account": null,
  "summary": "As Medicare's GLP-1 Bridge program gets underway in earnest and questions remain about the long-term use of these drugs, Eli Lilly is offering a new look at how older adults fare on its medication, Zepbound.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}